Last data update: Mar 17, 2025. (Total: 48910 publications since 2009)
Records 1-3 (of 3 Records) |
Query Trace: Odunsi S[original query] |
---|
A decade of implementing preexposure prophylaxis (PrEP) clinical guidelines: The vital role of nurses to expand access to PrEP in the United States
Kamitani E , Carnes N , Patel R , Ballard D , Bonacci RA , Odunsi S . J Assoc Nurses AIDS Care 2024 35 (5) 373-375 |
HIV: California's 2018 criminalization reform and testing among those reporting risk behavior
Keralis JM , Bourbeau A , Delaney KP , Odunsi S , Valentine SS . J Public Health Policy 2024 HIV criminalization laws may discourage HIV testing. We tested whether California's 2018 HIV criminalization law reform increased the likelihood of past-year HIV testing compared to Nevada, which did not reform its HIV criminalization law. We fitted two difference-in-differences logistic regression models: one for all respondents reporting behaviors that increase the chances of getting or transmitting HIV, and one for male respondents reporting these behaviors. All analyses accounted for the complex survey design of BRFSS. HIV criminalization reform was significantly associated with an increased likelihood of past-year HIV testing. After reform, the predicted marginal probability of past-year HIV testing increased by six percentage points. By comparison, probabilities of a past-year HIV test decreased in Nevada. HIV criminalization law reform may increase the likelihood of getting tested by individuals who engage in behaviors that increase the chances of getting or transmitting HIV. |
Dolutegravir Use at Conception - Additional Surveillance Data from Botswana
Raesima MM , Ogbuabo CM , Thomas V , Forhan SE , Gokatweng G , Dintwa E , Petlo C , Motswere-Chirwa C , Rabold EM , Tinker SC , Odunsi S , Malima S , Mmunyane O , Modise T , Kefitlhile K , Dare K , Letebele M , Roland ME , Moore CA , Modi S , Williamson DM . N Engl J Med 2019 381 (9) 885-887 In May 2018, an unscheduled analysis from the Botswana-Harvard AIDS Institute Partnership Tsepamo birth-outcomes surveillance study showed a higher prevalence of neural-tube defects among infants born to women who were using dolutegravir-based antiretroviral treatment (ART) regimens at the time of conception relative to infants born to women taking other types of ART.1 In response to this safety signal, the Botswana Ministry of Health and Wellness expanded surveillance for neural-tube defects in selected non-Tsepamo health facilities. |
- Page last reviewed:Feb 1, 2024
- Page last updated:Mar 17, 2025
- Content source:
- Powered by CDC PHGKB Infrastructure